ResearchIt
Active Member
For those of us with average T levels and/or higher SHBG, our bodies are producing enough T, they just aren't using what's there because it is being bound by SHBG and isn't bioavailable.
Why hasn't the pharmaceutical industry focused on producing medications that control (increase/decrease) levels of SHBG? That seems like a more useful approach than TRT in some cases and it would be a gold mine for them.
Why hasn't the pharmaceutical industry focused on producing medications that control (increase/decrease) levels of SHBG? That seems like a more useful approach than TRT in some cases and it would be a gold mine for them.